The RNA-guided CRISPR-associated (Cas) proteins Cas9 and Cas12a provide adaptive immunity against invading nucleic acids, and function as powerful tools for genome editing in a wide range of organisms. Here we reveal the underlying mechanisms of a third, fundamentally distinct RNA-guided genome-editing platform named CRISPR-CasX, which uses unique structures for programmable double-stranded DNA binding and cleavage. Biochemical and in vivo data demonstrate that CasX is active for Escherichia coli and human genome modification. Eight cryo-electron microscopy structures of CasX in different states of assembly with its guide RNA and double-stranded DNA substrates reveal an extensive RNA scaffold and a domain required for DNA unwinding. These data demonstrate how CasX activity arose through convergent evolution to establish an enzyme family that is functionally separate from both Cas9 and Cas12a.
. Metagenomic analysis of microbial DNA from groundwater samples revealed a new protein-which we refer to here as CasX (a placeholder name, pending re-analysis of the class 2 CRISPR-Cas phylogeny; CasX is also known as Cas12e 5 )-that prevented bacterial transformation by plasmid DNA when expressed with cognate crRNAs that target the plasmid 8 . Sequence analysis of CasX revealed no similarity to other CRISPR-Cas enzymes, except for the presence of a RuvC nuclease domain that is also found in both Cas9 and Cas12a enzyme families, transposases, and recombinases 8 . Phylogenetic analysis suggests that CasX arose from a TnpB-type transposase by an independent insertion event into ancestral CRISPR loci, distinct from Cas12a and the remaining type V effectors (Extended Data Fig. 1a ). Consistent with this hypothesis, the only conserved part of CasX, the RuvC domain, shares less than 16% identity with RuvC domains in either Cas9 or Cas12a (Extended Data Fig. 1b) . The evolutionary ambiguity of CasX hinted that this enzyme may have a structure and molecular mechanism distinct from that of other CRISPR-Cas enzymes. However, without full reconstitution of the CasX enzyme, it has not been possible to determine the basis of the previously reported plasmid interference activity.
Here we demonstrate that CasX is an RNA-guided DNA endonuclease that generates a staggered double-stranded break in DNA at sequences complementary to a 20-nucleotide segment of its guide RNA. We further find that CasX induces programmable, site-specific genome repression in E. coli and genome editing in human cells. Eight molecular models of CasX in different states (Supplementary Table 1 ), determined by cryo-electron microscopy (cryo-EM), reveal an unanticipated quaternary structure in which the RNA scaffold dominates the architecture and organization of the enzyme. Phylogenetic, biochemical and structural data show that CasX contains domains distinct from-but analogous to-those found in Cas9 and Cas12a, as well as novel RNA and protein folds; thus establishing the CasX enzyme family as the third CRISPR-Cas platform that is effective for genetic manipulation. Finally, distinct conformational states observed for CasX suggest an ordered non-target-and target-strand cleavage mechanism that may explain how CRISPR-Cas enzymes with a single active site, such as Cas12a, achieve double-stranded DNA (dsDNA) cleavage 5, 9, 10 . The small size of CasX (<1,000 amino acids), its DNA cleavage characteristics, and its derivation from non-pathogenic microorganisms offer important advantages over other CRISPR-Cas genome-editing enzymes.
. Unlike Cas9, Cas12a becomes a highly active single-stranded DNA (ssDNA) nuclease after binding to target DNA, triggering nonspecific ssDNA degradation 12, 13 . To test whether CasX displays similar non-specific activity, single-stranded phage DNA was incubated with DpbCasX-guide RNA complexes that target a separate, unrelated dsDNA substrate. We found that trans-ssDNA cutting activity was minimal compared to that observed for Lachnospiraceae bacterium Cas12a (LbCas12a) and another related Cas12b enzyme (Fig. 1e) . These results indicate that the presence of a single active site for dsDNA cleavage does not necessarily correspond to target-dependent trans-cleavage activity, hinting at structural and mechanistic differences between these enzyme families.
CasX enacts genome silencing and editing
To determine whether the RNA-guided DNA cutting activity of CasX can be harnessed for programmed genome targeting, DpbCasX and its sgRNA were expressed in E. coli using a guide sequence that is complementary to an integrated reporter in the genome of bacterial strain MG1655 14, 15 . We found that DpbCasX reduced cell viability in a genome cleavage assay at close to-but slightly less than-the activity levels of Streptococcus pyogenes Cas9 (SpCas9) (Fig. 2a) . We next tested whether CasX can function as an effector of CRISPR interference (CRISPRi) in E. coli. By aligning the RuvC domain among CasX and other Cas proteins, we found three potential active site residues: Asp672, Glu769 and Asp935. Biochemical screening indicated that mutating these residues to alanine-individually or in combinationcreates a deactivated DpbCasX (Extended Data Fig. 1d ) that is competent for RNA-guided DNA binding and gene repression rather than cutting (Fig. 2b) . Silencing of green fluorescent protein (GFP) expression was observed with this deactivated DpbCasX construct using different guide RNAs that target multiple sites within the gene that encodes GFP (Extended Data Fig. 1e ). We found that mutation of all three DpbCasX residues was required for maximal gene repression activity (Extended Data Fig. 1f ). CasX-based bacterial CRISPRi thus provides an ideal system for rapid, visual and quantitative in vivo characterization of CasX constructs (Fig. 2c, d, Extended Data Fig. 1e ).
We next tested whether CasX is capable of inducing cleavage and gene editing of mammalian genomes. Using a previously reported destabilized-GFP disruption assay 15 ( Fig. 2e) , we found that DpbCasX can induce targeted GFP gene disruption in HEK293T cells with limited efficiency, using guide RNAs complementary to either the template or the coding strand (guide 2 or guide 3, respectively) (Fig. 2f) . We also explored the effectiveness of the CasX molecule from Planctomycetes (PlmCasX), which bears approximately 70% sequence identity to DpbCasX and can use the same sgRNA 8 . We find that PlmCasX enacts destabilized-GFP gene editing with higher efficiency than DpbCasX. Because the guide RNA that recognizes the coding strand functioned more robustly in each case, we wondered whether the additional GFP gene disruption observed for guide 3 could be explained by RNA targeting 4, 16 . Nevertheless, there was no recovery of GFP expression in these cells over time (Fig. 2g) , which is consistent with genome editing rather than transcript targeting. Furthermore, analysis of DNA derived from the PlmCasX-targeted GFP locus using a T7E1-based assay 17 revealed levels of genome editing consistent with Cartoons are scaled according to the gene size. Bottom, schematic of the CasX dual-guide RNA and single guide; tracrRNA in grey, crRNA in teal and the target DNA in black. TS and NTS denote target strand and nontarget strand, respectively. The RNA loop that connects the tracrRNA and crRNA is depicted in red. aa, amino acids. b, DNA cleavage efficiency by DpbCasX. P indicates the cleavage product. The cleavage fraction is calculated on the basis of the NTS band density compared to input NTS band density at reaction time of 0 min. c, Cleavage site mapping of DpbCasX and LbCas12a. Lane M shows labelled ladders. d, The cleavage sites for NTS and TS (marked with black arrows). e, Cleavage activity of DpbCasX on trans-ssDNA. The cleavage fraction is calculated based on the trans-ssDNA band density compared to input trans-ssDNA band density at reaction time of 0 min. AaCas12b, Alicyclobacillus acidoterrestris Cas12b. Four biological repeats for all the assays showed consistent results.
Article reSeArcH the observed GFP disruption (Extended Data Fig. 2a, b) . Next, we explored the effect of the concentration of the plasmid that encodes CasX sgRNA on the extent of genome editing. The highest amounts of transfected PlmCasX plasmid produced GFP-locus editing at levels comparable to the levels of genome editing observed in initial reports for CRISPR-Cas9 and CRISPR-Cas12a (about 34%) 6, 7, 11, 18 (Extended Data Fig. 2c ). Additionally, we developed two distinct clonal EGFP HEK293T reporter lines (labelled 1 and 2) using lentiviral integration. PlmCasX-mediated EGFP disruption in these individual cell lines was comparable to results in the destabilized-GFP reporter cell line, with guide 3 producing higher levels of editing than guide 2 (Extended Data  Fig. 2d ). Sub-cloning PCR-amplified segments of the GFP locus from treated cells revealed a wide variety of indels, many of which map to the cut sites identified in vitro (Extended Data Fig. 2e ). Finally, we compared the editing efficiency of PlmCasX to that of SpCas9, which has been optimized over the past six years for high efficiency. In most cases, guide RNAs for both Cas9 and CasX recognize the EGFP locus at similar locations but with offsets to accommodate differences in PAM specificity (Extended Data Fig. 2f ). By using an optimized transfection protocol, we observe that 9 out of 10 CasX guide RNAs disrupt GFP and that editing efficacy is on average about 30% that of SpCas9-and in some cases individual guides edit as high as 55% of cells (guide 3) (Fig. 2i, Methods) . These results demonstrate that CasX belongs to a third, distinct class of CRISPR systems that is capable of targeted genomic regulation and editing, and motivated experiments aimed at determining the structural and mechanistic basis for these activities.
CasX has a unique domain composition
To understand how CasX (all structural characterizations were performed using DpbCasX) binds to DNA, a ternary complex containing deactivated CasX (D672A/E769A/D935A), sgRNA (122 nucleotides) and a complementary DNA substrate (30 base pairs (bp)) was analysed by single-particle cryo-EM (Extended Data Fig. 1g ). Three-dimensional particle classification and refinement revealed two conformational populations of the ternary complex, at resolutions of 3.7 Å (state I) and 4.2 Å (state II) (Extended Data Fig. 3 ). These two conformational states were also observed by cryo-EM analysis of a CasX complex containing a full R-loop (45-bp DNA substrate), refined at resolutions of 3.2 Å (state I) and 5.2 Å (state II) (Extended Data Fig. 4 ). With the cryo-EM maps, atomic models of CasX ternary complexes in state I and state II were built ab initio (Extended Data Fig. 5 ). Although structural alignment of the entire modelled polypeptide chain revealed some similarity between CasX and Cas12a (Lachnospiraceae bacterium Cpf1 (LbCpf1), RCSB Protein Data Bank (PDB) code 5XUU); z-score 15.1, with a root mean square deviation (r.m.s.d.) value of 5.3 Å for 671 aligned residues) 19 , a more detailed analysis of the domains showed that-as expected-this similarity results from the RuvC domain and oligonucleotide-binding domain (OBD); alignment of RuvC with LbCpf1 PDB 5XUT gives a z-score of 13.8 and an r.m.s.d. value of 2.5 Å for 173 aligned residues, and alignment of the OBD with LbCpf1 PDB 5XH6 gives a z-score of 9.6 and an r.m.s.d. value of 3.5 Å for 153 aligned residues 10, 20 . Although CasX contains additional structural elements that appear analogous to those identified in other Cas proteins (including the helical I and helical II domains, and the REC1 and REC2 domains), these domains have highly distinct folds (Extended Data Fig. 6a, b) .
Two domains were identified adjacent to the separated DNA strands in the CasX complex, which we refer as the non-target-strand binding (NTSB, residues 101-191 (red in Fig. 3a, b) ) and the target-strand loading (TSL, residues 825-934 (pink in Fig. 3a, b) ) domains. The NTSB domain contains a four-stranded β-sheet and sits next to the non-target strand of the DNA (Fig. 3b) . We discuss this domain and its function in depth below. The TSL domain is located in a position analogous to that of the so-called 'Nuc' , a domain that was incorrectly hypothesized to be a second nuclease domain responsible for DNA cleavage, in other type V CRISPR-Cas enzymes 9, 13 . We propose that Nuc and similar domains should be renamed TSL to better explain the activity that we postulate to be target-strand placement in the RuvC active site 10 . In the Acidaminococcus sp. Cas12a Nuc domain, amino acids Arg1226 and Asp1235 aid target-strand cleavage, and an Arg1226Ala mutation produced an Acidaminococcus sp. Cas12a nickase by abolishing the ability of Cas12a to cut the target strand 9 . In the TSL domain of CasX, residues Arg917 and Gln920 interact with DNA (non-target strand in state I and target strand in state II) that is adjacent to the active site (Fig. 3c) . Within the CasX full R-loop structure in state I, a TSL loop that contains three tyrosines (Tyr867, Tyr868 and Tyr870) and three positively charged residues (Arg869, Lys871 and Arg872) interacts with the migration point at which the RNA-DNA duplex ends and the DNA-DNA duplex reforms (Fig. 3d, Extended Data Fig. 6c ). In other enzymes, similar loops or hairpin elements that contain a large hydrophobic amino acid (tyrosine or phenylalanine) are thought to be involved in DNA strand separation [21] [22] [23] . Moreover, the TSL domain also contains two CXXC motifs (residues 824-827 and 926-929) that form a tetra-Cys zinc-finger or zinc ribbon motif (Extended Data  Fig. 6c, d ), akin to those found in phage primases, transcription factors and the purported transposase ancestor for type V CRISPR proteins TnpB5 5, [24] [25] [26] . Together, it is clear that CasX possesses domains analogous to other CRISPR-Cas proteins as well as completely novel domains, as anticipated by its complete sequence dissimilarity from other CRISPR proteins.
A prominent guide RNA scaffold for CasX
Structural modelling shows that the guide RNA accounts for about 26% of the mass in the CasX-sgRNA binary complex, which is a value that is greater than those observed for other type II or type V CRISPR-Cas effector complexes (about 8% in LbCas12a, about 20% in Alicyclobacillus acidoterrestris Cas12b and about 16% in SpCas9; Extended Data Fig. 6e ). Dominating the CasX protein complex, the sgRNA includes three elements: a triplex stem-loop that contacts the OBD, a 'scaffold' stem that interacts with the helical II domain and a perpendicular stem-loop that projects away from the centre of mass of the structure (Fig. 3e , f, Supplementary Video 1). Alterations to the triplex or the scaffold stem diminished CasX activity in vivo, whereas truncated versions of the perpendicular stem-loop retained activity (Extended Data Fig. 6f ).
In the absence of guide RNA, the CasX protein is poorly resolved by cryo-EM (Extended Data Fig. 7a, d ). Consistent with the importance of RNA in CasX protein architecture, CasX cross-linking before and after addition of the sgRNA followed by analytical mass spectrometry revealed large RNA-induced CasX domain rearrangements (Extended Data Fig. 7e, g ). In line with this analysis, a cryo-EM-derived model of the CasX-sgRNA complex (a map at about 7.5 Å resolution) shows the OBD, RuvC and helical II domains assembled along the RNA scaffold, Article reSeArcH whereas the NTSB domain associates with the RuvC, helical I and helical II domains near the nuclease active site (Extended Data Fig. 6 b, f). Comparison with the DNA-bound structure shows that, upon DNA binding, the NTSB domain moves away from the centre of mass of the complex (Extended Data Fig. 7c , h, i).
Two conformations enable CasX dsDNA cleavage
Comparison of the two conformational states (states I and II) of the CasX ternary complex revealed a large structural change that alters target DNA strand accessibility to the RuvC domain (Fig. 3c, d , Supplementary Video 2). In state I, the non-target-strand DNA sits in the RuvC active site while the target-strand DNA-guide RNA duplex engages with the helical I and helical II domains (Fig. 3b, d) . In state II, the target-strand DNA-guide RNA duplex is sharply bent, which allows RuvC access to the target-strand DNA (Fig. 3c) . State I is compatible with non-target-strand DNA cleavage, whereas state II is compatible with cleavage of the target-strand DNA (Fig. 3g, Extended  Data Fig. 7j, k) .
Statistical analysis by single-particle sorting showed that the majority of particles (about 71%) in the 30-bp target DNA ternary complex adopted the state I conformation, and that the remaining 29% of particles were in state II (Fig. 4a, Extended Data Fig. 3 ). This preference suggests that non-target-strand DNA is cleaved by the RuvC domain first, followed by displacement and target-strand cleavage. Similar to the 30-bp DNA-containing sample, 67% of full R-loop (45-bp) DNA particles adopted state I (Fig. 4b, Extended  Data Fig. 4) .
In our sequential model of CasX-mediated DNA cleavage, a substrate-bound complex mimicking the intermediate state that occurs after non-target-strand cleavage should preferentially adopt state II. To test this idea, we performed cryo-EM analysis on a CasX ternary complex that contained sgRNA and a DNA substrate comprising a 45-nucleotide target strand and a post-cleavage-like 20-nucleotidenon-target strand (Extended Data Fig. 8 ). In this intermediate-state sample, most particles (about 66.4%) adopted the state II conformation, and the target strand was located near the RuvC active site (Fig. 4c) . Reconstruction of state I showed the 5′-end overhang of the target-strand DNA folded back into the RuvC domain. This conformation is incompatible with dsDNA cleavage at position 22 and is unlikely to occur natively (Figs. 1d, 4c) .
The CasX NTSB domain is required for DNA unwinding
The distinct and smaller architecture of CasX relative to other dsDNA-targeting CRISPR enzymes implies a unique mechanism of substrate recognition, which requires guide RNA strand invasion into duplex DNA. The observation that the NTSB domain interacts directly with non-target DNA strand both in state I and state II (Fig. 5a ) Completely base-paired probe and a bubbled probe were used to test the on-target activity, and a random 50-nucleotide oligonucleotide was used to test the trans-cleavage activity. P indicates the cleavage product. Three biological repeats for the assays showed consistent results.
raised the possibility that this structure contributes fundamentally to the mechanism of DNA unwinding. To test this hypothesis, we analysed the behaviour and activity of a protein construct that lacks the NTSB domain (CasXΔ101-191). Although it showed similar physical behaviour to that observed for the wild-type CasX on a size-exclusion column (Extended Data Fig. 9a ), CasXΔ101-191 was incapable of cleaving a dsDNA substrate (Fig. 5b) . Nevertheless, CasXΔ101-191 retains robust targeted ssDNA cleavage activity, including on mismatched duplex DNA substrates (Fig. 5b, Extended Data Fig. 9b ). Of note, CasXΔ101-191 has slightly higher trans-cleavage activity than does wild type, suggesting that the NTSB domain may contribute to shielding the RuvC from accessing the trans-DNA substrates (Fig. 5b) . Together, these results suggest that the NTSB domain is responsible for initiating and/or stabilizing DNA duplex unwinding by CasX. This finding also hints at the interesting possibility that the self-contained NTSB domain could be introduced into or acquired by other enzymes to assist with or stabilize dsDNA binding.
Conclusions
On the basis of our functional and structural data, we propose a model of CasX activation and DNA cleavage that includes the following steps:
(1) guide RNA binding-induced CasX structural stabilization and DNA search; (2) NTSB-assisted DNA unwinding, R-loop formation and nontarget-strand loading into the RuvC active site; (3) RNA-DNA hybrid duplex bending with the aid of the proposed TSL domain to position the target DNA strand for cleavage; and (4) product release after the cleavage of both DNA strands (Extended Data Fig. 10 ). Two distinct target DNA-bound states indicate that CasX coordinates sequential dsDNA cleavage by its single RuvC nuclease using the zinc-fingercontaining TSL domain (Extended Data Fig. 10c, d ). The TSL domain appears to confer a convergent mechanism of acute target-strand DNA bending that is central to all type V single-nuclease CRISPRCas enzymes. These functional insights will enable the continued development of CasX as a third platform for RNA-programmed genome editing. The compact size, dominant RNA content and minimal trans-cleavage activity of CasX differentiate this enzyme family from Cas9 and Cas12a, and provide opportunities for therapeutic delivery and safety that may offer important advantages relative to existing genome-editing technologies.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. 27 and cleavage assays described below use E. coli MG1655 containing genomically integrated and constitutively expressed GFP and red fluorescent protein (RFP). Standard cloning techniques were used to create all plasmids. Plasmid construction and retention was ensured with AmpR and CmR as selectable markers 15 . EZ-rich defined growth medium (EZ-RDM, Teknova) was used in all CRISPRi assay fluorescent measurements; 2×YT (LB) with the addition of 1.5% Bacto Agar (BD) was used for all plating assays. E. coli assays. CRISPRi assays were performed in a similar manner to previous work 15 . In brief, to test the ability of CasX to bind genomic DNA and repress transcription, electrocompetent E. coli were co-transformed with a plasmid encoding the guide RNA and a plasmid encoding the CasX protein as described. They were grown on medium containing two antibiotics to ensure selection for both plasmids. Colonies were picked in triplicate from these plates into EZ-RDM liquid medium and grown for 12 h. These saturated cultures were diluted 1:1,000 into EZ-RDM medium containing 2 nM anhydrotetracycline inducer and 150 μl of this mixture was followed for OD 600 and GFP (a.u.) via a 96-well microplate reader (Tecan m1000) every 10 min over the course of 12 h at 37 °C, unless otherwise noted.
Strains and media. The in vivo CRISPRi
To perform the bacterial genome targeting assay, 100 ng of the CRISPR-Cas protein-encoding plasmid was electroporated into electrocompetent MG1655 E. coli expressing the GFP-targeting sgRNA plasmid using a BTX Harvard apparatus ECM 630 High Throughput Electroporation System, in biological triplicate. The guide sequence was moved onto the protein-encoding plasmid and 200 ng of this was used in the transformation. The cells were recovered for one hour in 300 μl SOC medium at 37 °C, unless otherwise noted. Two technical replicates of tenfold serial dilutions were spotted onto plates containing antibiotics for the plasmid(s) used in the transformation. These grew at either 37 °C for 12 h or 30 °C for 16 h and were used to calculate CFU per ml. Human-cell GFP disruption. The EGFP reporter construct was created in a modified lentivirus backbone with EF1-alpha promoter driving the EGFP gene of interest, and a second PGK promoter driving production of hygromycin. Transduced 293T cells, validated and mycoplasma-free (tested by the UC Berkeley Cell Culture Facility), were selected with hygromycin (used at 250 μg/ml). EGFP clones were isolated by sorting single cells into 96-well plates and characterized by intensity of EGFP. Lentivirus was produced by PEI (Polysciences, 24765) transfection of 293T cells with gene delivery vector co-transfected with packaging vectors pspax2 and pMD2.G, essentially as previously described 28 . HEK293T EGFP experiments were conducted in a similar manner to previous assays. In brief, the EGFP HEK293T reporter cells were seeded into 96-well plates and transfected according to the manufacturer's protocol with lipofectamine 2000 (Life Technologies) and the described amount of plasmid DNA encoding the CasX, sgRNA and CasX, P2A-puromycin fusion. The next day cells were selected with 1.5 μg/ml puromycin for 3 days and analysed by fluorescence-activated cell sorting 8 days after selection to allow for clearance of EGFP protein from the cells. Cells were passaged once to maintain sub-confluent conditions. EGFP expression was traced using an Attune NxT Flow Cytometer and high-throughput autosampler. For extended assays, cells were passaged 1:10 and reanalysed on the date notes. The PlmCasX versus SpCas9 EGFP line 1 disruption assays were done as described above, but the protocol was improved by using lipofectamine 3000 instead of 2000, according to the manufacturer's protocols, selecting with 1.5 μg of puromycin for 48 h and analysing 11 days later. T7EI assay. T7EI assays were performed as previously described with slight modification 15 . In brief, cells were suspended 1:1 in QuickExtract (lucigen) buffer and DNA was extracted using the manufacturer's protocol. This mixture was used directly in a PCR reaction designed to amplify the GFP locus and ~200 ng of PCR product was used for denaturing, annealing and digestion with T7E1 (NEB), according to the manufacturer's protocol. Samples were analysed on a 2% agarose gel with SYBRsafe (Thermo Fisher). EGFP fragment sub-cloning and sequencing. The edited GFP locus was amplified via PCR from HEK cells treated with Quick Extract buffer. The PCR fragments were then T4 blunt-ligated into a small ColEI plasmid that was digested with PmeI and treated with CIP. Ligation products were transformed into cells and colonies were grown overnight before being picked, Miniprepped (Qiagen) and Sangersequenced at the UC Berkeley DNA Sequencing Facility. Sequencing results were aligned to the target and visualized via Snapgene. Protein expression, purification and complex reconstitution. The gene encoding CasX was sub-cloned into the 2CT-10 expression vector. CasX(D672A/E769A/ D935A) and CasXΔ101-191 were obtained by amplifying the CasX plasmid using mutagenetic PCR primers. All the proteins were expressed using Rosetta E. coli cells. Main culture (Terrific broth, containing 100 mg/l ampicillin) was inoculated with 3% of overnight culture grown in Luria broth. The main culture was grown to an OD of 0.5-0.6, cooled down and protein expression was induced by addition of IPTG to a final concentration of 0.5 mM, and expression was allowed to proceed overnight at 16 °C. Cells were collected, re-suspended in Ni buffer A (500 mM sodium chloride, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP) and frozen at −80 °C For wild-type CasX protein preparation, cells were thawed, diluted twice with Ni buffer A, followed by addition of PMSF (final concentration 0.5 mM), and 3 tablets of Roche protease inhibitor cocktail per 100 ml of cell suspension. Cells were lysed by sonication and pelleted at 35,000g for 30 min. Clarified lysate was purified using Ni-NTA agarose beads, using step-gradient elution with imidazole-containing buffer (Ni buffer B (highest imidazole concentration): 500 mM sodium chloride, 500 mM imidazole, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP). The pure fractions were pooled and TEV protease was added (1 mg protease/20 mg purified protein in final concentration). The protein with TEV protease was dialysed overnight against the following buffer: 500 mM sodium chloride, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP. Then, protein was applied to a maltose binding protein (MBP) column and the MBP flow-through was applied to a heparin column. Protein was eluted from the heparin column using a sodium chloride gradient up to 1 M sodium chloride. For the wild-type protein, there were two peaks containing CasX. The peak that eluted at lower salt concentration was found to contain inactive and aggregated protein and was not pooled; only the second peak contained active protein and only that protein was used for the assays. The active protein from the heparin column was concentrated and applied to a Superdex200 10/300 column in the following buffer: 500 mM potassium chloride, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP. Pure protein was concentrated and flash-frozen. CasXΔ101-191 purification was purified as the same way as wild-type CasX. The overall expression yield was similar, but the amount of the well-folded protein (second peak) was lower than in case of wild-type protein. For CasX(D672A/E769A/D935A), the purification was similar, except that dialysis buffer was: 300 mM sodium chloride, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP and size-exclusion buffer was 300 mM potassium chloride, 50 mM HEPES, pH 7.5, 10% glycerol, 0.5 mM TCEP, and all the protein eluted as a single well-folded protein peak on heparin column.
sgRNA was in vitro-transcribed using T7 RNA polymerase and purified using 10% urea-PAGE. The in vitro transcription template w as G AA ATTAATACGAC TCACTATAggCGCGTTTATTCCATTACTTTGGAGCCAGTCCCAGCGACT ATGTCGTATGGACGAAGCGCTTATTTATCGGAGAGAAACCGATAAGTA AAACGCATCAAAGTCCTGCAGCAGAAAATCAAA.
The CasX-sgRNA complex was assembled by incubating protein with 1.6-fold stoichiometric excess of sgRNA for 30 min at room temperature. The ternary complexes were assembled by incubating CasX-sgRNA with 1.8-fold stoichiometric excess of annealed DNA target for 30 min at room temperature. After the complexes were assembled, they were purified by size-exclusion chromatography using Superdex200 10/300 column. DNA cleavage assays. DNA substrates were 5′-end-labelled with T4 PNK (NEB) in the presence of gamma 32 P-ATP. Unless otherwise noted, the following conditions were used: proteins were diluted to 4 μM with dilution buffer (500 mM NaCl, 10% glycerol, 20 mM Tris-HCl, pH 7.5, 1 mM magnesium chloride, 0.5 mM TCEP). sgRNA was diluted to 6 μM with reaction buffer (20 mM HEPES, pH 7.5, 10 mM magnesium chloride, 150 mM potassium chloride, 1% glycerol, 0.5 mM TCEP). Resulting stocks of protein and sgRNA were mixed in 1:1 molar ratio and incubated for 10 min at room temperature to produce active complex. Cleavage reactions were conducted in 1× reaction buffer; the radiolabelled probe concentration was 2 nM. Reactions were initiated by addition of CasX-sgRNA to a final concentration of 200 nM. The reactions were conducted at 37 °C, and aliquots were taken at the following time points: 0, 2, 5, 30, 60 and 120 min. The aliquots were immediately mixed with formamide loading buffer (final concentration 45% formamide and 50 mM EDTA, with trace amount of bromophenol blue) and heated for 10 min at 90 °C for quenching. Samples were separated by 10% or 12% urea-PAGE, gels were dried and the results were visualized using a phosphoimager (Amersham Typhoon (GE Healthcare)).
In the cleavage assays used to determine the DNA cut sites (Fig. 1b, c) , the following concentrations were used: 100 nM Cas protein and 120 nM guide RNA. In the experiment in which trans-cleavage activity was compared between different CRISPR-Cas proteins (Fig. 1e) the following concentrations were used: 100 nM Cas proteins, 120 nM guide RNA, 150 nM activator and M13mp18 ssDNA (New England Biolabs). In the experiments in which trans-cleavage activity was compared between CasX and CasXΔ101-191, a random 50-nucleotide oligonucleotide substrate was used. All the nucleotide sequences and plasmids used in this study have been summarized in Supplementary Table 2 . Electron microscopy sample preparation and data collection. CasX complexes in a buffer containing 20 mM HEPES, pH 7.5, 150 mM KCl, 1 mM DTT and 0.25% glycerol were used for cryo-EM sample preparation. Immediately after glow-discharging the grid for 14 s using a Solaris plasma cleaner, 3.6-μl droplets of the sample (~3 μM) were placed onto C-flat grids with 2-μm holes and 2-μm spacing between holes (Protochips). The grids were rapidly plunged into liquid ethane using a FEI Vitrobot MarkIV maintained at 8 °C and 100% humidity, after being blotted for 4 s with a blot force of 8. Data were acquired using an FEI Titan Krios transmission electron microscope operated at 300 keV with a GIF energy filter, at a nominal magnification of 135,000× (0.9-Å pixel size) for ternary complexes and 105,000× (1.15-Å pixel size) for binary complex, with defocus ranging from −0.5 to −2 μm. Micrographs were recorded using SerialEM on a Gatan K2 Summit direct electron detector operated in super-resolution mode 29 . We collected a 4.8-s exposure fractionated into 32, 150-ms frames with a dose of 9.58 e − Å −2 s −1
. Apo-CasX in a buffer containing 20 mM HEPES, pH 7.5, 500 mM NaCl, 1 mM DTT and 5% glycerol was used for cryo-EM sample preparation following the same sample protocol used for CasX complexes. Data were acquired using a FEI Titan Krios transmission electron microscope operated at 300 keV with energy filter and Volta phase plate, at a nominal magnification 105,000× (1.15-Å pixel size) with defocus of about −0.5μm. Electron microscopy data analysis. For CasX binary and ternary complexes, the 28 frames (we skipped the first 2 and last 2 frames) of each image stack in super-resolution model were aligned, decimated, summed and dose-weighted using Motioncor2 30 . CTF values of the summed-micrographs were determined using Gctf 31 . Initial particle picking to generate template images was performed using EMAN2 32 . About 10,000 particles were selected and then imported into Relion2.0 for reference-free 2D classification 33 . Particle picking for the complete data set was carried out using Gautomatch (by K. Zhang, unpublished) with templates generated in the previous 2D classification. Local CTF was re-calculated by Gctf with the determined box files. Particles were extracted from the doseweighted, summed micrographs in Relion2.0 and then imported into CryoSparc 34 for 2D classification, ab initio modelling, heterogeneous refinement, homogenous refinement and local resolution calculation.
For images obtained with a Volta phase plate, following preprocessing the CTF and phase-shift values of the summed-micrographs were determined using Gctf and then applied to dose-weighted, summed micrographs for further processing. Parameters in the electron microscopy analysis for the five CasX samples have been summarized in Supplementary Table 1 . Cross-linking and mass spectrometry. CasX samples in HEPES buffer were crossed-linked using 1 mM bis-sulfosuccinimidyl-suberate (BS3) at 30 °C for 30 min. The reactions were stopped by adding 50 mM Tris (final concentration). Cross-linked samples were then digested by trypsin and purified for mass spectrometry analysis. Cross-linked peptides were identified using an upgraded version of pLink 35 . In pLink, the parameter of cross-linker was set to BS3. The parameter of enzyme was set to trypsin with up to three missed cleavages. Precursor mass tolerance and fragment mass tolerance were both set to 20 ppm. At least six amino acids were required for each peptide chain. Carbamidomethylation on cysteine was searched as a fixed modification. Oxidation on methionine was searched as a variable modification. Search results were filtered by requiring false discovery rate < 5% at the spectral level. Further inspection of tandem mass spectrometry spectra were performed using pLabel 36 . Atomic model building. For the CasX ternary complex containing a 30-bp target DNA, the cryo-EM density of state I at 3.7 Å resolution was used for secondary structure search in PHENIX with the 'Find Helices and Strands' program 37 . The protein main chain was manually traced in Coot 38 . After main chain building, side chains were assigned manually based on the electron microscopy map in Coot and were then further improved using the cryo-EM map of state I with the full R-loop at a resolution of 3.2 Å. The DNA substrates and gRNA were manually built ab initio in Coot based on the cryo-EM density. To improve backbone geometry, the atomic model was subjected to PHENIX real-space refinement (global minimization and ADP refinement) with secondary structure, Ramachandran, rotamer and nucleic-acid restraints. The final model was validated using Molprobity 39 and cross-linking mass spectrometry data. The atomic models of state II were obtained by running flexible fitting on the state I atomic model against the state II cryo-EM map (4.2 Å resolution) with secondary structure restraints in MDFF 40 . PHENIX real-space refinement was further used to improve backbone geometry. This state II atomic model was directly adopted for structural interpretation of the CasX ternary-complex state II with full R-loop DNA and shortened non-target strand DNA.
For the CasX ternary complex containing a full R-loop DNA, the atomic model of CasX ternary-complex state I with 30-bp target DNA was fitted into the state I cryo-EM map of CasX ternary complex containing full R-loop DNA (resolution of 3.2 Å) using UCSF Chimera 41 . Additional DNA nucleotides were manually built in Coot. The atomic model was subjected to PHENIX real-space refinement against the cryo-EM map and validated using Molprobity.
For the CasX ternary complex containing a shortened non-target-strand DNA, the atomic model of CasX ternary-complex state I with 30-bp target DNA was fitted into the state I electron microscopy map of CasX ternary complex containing the shortened non-target-strand DNA (resolution 4.5 Å) using Chimera. DNA nucleotides were manually modified in Coot. The atomic model was subjected to PHENIX real-space refinement against the cryo-EM map and validated using Molprobity. X-ray fluorescence elemental analysis. Targeted proteins at a concentration of around 1 μg/μl were mixed with 4 volumes of acetone and incubated at −20 °C for 1 h. Precipitated proteins were collected by centrifugation. The protein pellets were smashed in the buffer containing 50 mM Tris, 150 mM NaCl and 0.03% dodecyl maltoside at pH 7.5, loaded on to a nylon loop and then flash-frozen in place on a goniometer using a nitrogen stream. The samples were excited with a 14-keV X-ray beam and fluorescence spectra were collected. Elements in the sample were identified on the basis of characteristic emission energies. RaxML maximum-likelihood phylogenetic tree. Cas12 proteins 8, 11, 42 were aligned with TnpB representatives using MAFFT 43 . Alignment columns were trimmed using the trimAl -gappyout method, and a maximum-likelihood phylogenetic tree was constructed using RAxML 44 with PROTGAMMALG as the substitution model and 100 bootstrap samplings. The family tree was visualized using iTOL v.3 45 . Sequence identity pairwise comparison. A non-redundant set of Cas9 orthologues (type II-A) was compiled by clustering proteins with ≥ 90% identity using CD-HIT 46 . Cas9, Cas12a and CasX proteins were each aligned separately using MAFFT and the RuvC domains for each protein in the alignment were inferred from their known crystal structures. A multiple sequence alignment of the resulting RuvC domains was used to extract the per cent identity of each pair of orthologues and generate a heat map that illustrates the pairwise comparisons of the RuvC domains. Histograms of the frequency of occurrence of each identity value in pairwise comparisons of Cas12a, Cas9 and CasX were plotted from the heat map. Reagent, software and protocol availability. All the reagents used in this work are commercialized. All the protocols have been described in detail above. All the software used in this work is noted with references, and is available for academic usage. Further requests for information regarding reagent, software and protocol availability should be addressed to the corresponding authors. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. 
Data availability
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Relion2.0, Cryosparc v1, Spider, EMAN2, Coot, Phenix2400, VMD-MDFF v0.4, UCSF-Chimera v1, Pymol v2, Snapgene V4, GraphPad Prism 7,Motioncor2, Gctf V1, Gautomatch V1, pLink1.9, pLabel2.8, Molprobity, MAFFT v7, RAxML v8, iTOL v3, CD-HIT For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The EM maps have been deposited to EMDB with the following accession codes: EMD-8987, EMD-8988, EMD-8980, EMD-8994, EMD-8996, EMD-8991, EMD-8989, EMD-8890. The refined atomic models have been deposited to PDB with the following accession codes: 6E50, 6E7A, 6E79
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All the unctted gels have been included in the source Data. CryoEM raw data and crosslinking data( > 10TB) are available upon email request.
Field-specific reporting Randomization For cryo-EM data collection, the exposure squares are randomly selected across the grid with good ice distribution. In cryoEM analysis, all the particles are randomly assigned to different classes in initial round, then generally converged in later rounds based on the cross correlation value with the class averages.
Blinding
No blinding was undertaken. All the exprements in this story are eitehr in vitro or cell based in vivo. Blindling is not applicable.
Reporting for specific materials, systems and methods 
Mycoplasma contamination
Cells were not re-tested for mycoplasma for this study, they were originally tested in the 2016 study, and The UC Berkeley Cell Culture Facility maintains verified mycoplasma free stocks.
Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
